%PDF-1.4
%
83 0 obj
<>
endobj
80 0 obj
<>
endobj
175 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-07-12T13:30:15Z
2024-03-28T01:35:52-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-28T01:35:52-07:00
application/pdf
Heather
2005-243-S75
uuid:b7a11866-1dd1-11b2-0a00-ba08278d5b00
uuid:b7a1186a-1dd1-11b2-0a00-1e0000000000
endstream
endobj
69 0 obj
<>
endobj
70 0 obj
<>
endobj
84 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 51 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 53 0 R/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 55 0 R/Type/Page>>
endobj
23 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 57 0 R/Type/Page>>
endobj
34 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 59 0 R/Type/Page>>
endobj
45 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 61 0 R/Type/Page>>
endobj
48 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 63 0 R/Type/Page>>
endobj
202 0 obj
[206 0 R]
endobj
203 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
0 0 0 1 K
/GS1 gs
53.964 72 m
558.036 72 l
S
0 0 0 0 k
/GS0 gs
104.25 77.083 407.5 -10.833 re
f*
0.5 w
/GS1 gs
104.25 77.083 407.5 -10.833 re
S
53.964 742.5 243.036 -541.553 re
f*
BT
0 0 0 1 k
/T1_0 1 Tf
0.02499 Tw 8 0 0 8 54.964 735.7637 Tm
[(27.)-496.1 (R)74 (ussell IJ)86.9 (,)-275 (Orr MD)50.1 (,)-275 (Littman B)29.1 (,)-275 (et al.)-275 (Ele)13.9 (v)20 (a)29 (ted cer)12.9 (e)14.9 (br)33.9 (ospinal f)-6.8 (luid)]TJ
1.7672 -1.2 Td
[(le)13.9 (v)13.9 (els of)-367.8 (substance P in pa)29.1 (tients with the fibr)33.9 (om)27.1 (y)20 (algia syndr)33.9 (ome)56.9 (.)]TJ
0 -1.2 TD
(Arthritis Rheum 1994;37:1593-601.)Tj
-1.7672 -1.2 Td
[(28.)-496.1 (Br)7.1 (adley LA,)-275 (Alar)12.9 (con GS)43 (,)-275 (Sotolongo A,)-275 (et al.)-275 (Cer)12.9 (e)14.9 (br)33.9 (ospinal f)-6.8 (luid)]TJ
1.7672 -1.2 Td
[(\(CSF\) le)13.9 (v)13.9 (els of)-367.8 (substance P \(SP\) ar)13 (e a)43 (bnor)-20.8 (mal in pa)29.1 (tients with)]TJ
T*
[(fibr)33.9 (om)27.1 (y)20 (algia \(FM\) r)12.9 (egar)13.9 (dless of)-367.8 (tr)7.1 (auma)29.1 (tic or insidious pain onset)]TJ
T*
[([a)43 (bstr)7.1 (act].)-275 (Arthritis Rheum 1998;41 Suppl:S256.)]TJ
-1.7672 -1.2 Td
[(29.)-496.1 (V)74 (aer)33.9 (o)35.9 (y H,)-275 (Helle R,)-275 (F)79.1 (orr)12.9 (e O)35.9 (,)-275 (K)13.9 (ass E,)-275 (T)74 (er)12.9 (enius L.)-275 (Ele)13.9 (v)20 (a)29.1 (ted CSF)]TJ
1.7672 -1.2 Td
[(le)13.9 (v)13.9 (els of)-367.8 (substance P and high incidence of)-367.8 (R)42 (a)40 (ynaud phenomenon)]TJ
T*
[(in pa)29.1 (tients with fibr)33.9 (om)27.1 (y)20 (algia:)-275 (ne)13.9 (w fea)29.1 (tur)13 (es f)40 (or dia)22 (gnosis)64 (.)-275 (P)12.9 (ain)]TJ
0 Tw T*
(1988;32:21-6.)Tj
0.02499 Tw -1.7672 -1.2 Td
[(30.)-496.1 (Neeck G)43 (,)-275 (Cr)33.9 (of)29.1 (f)40 (or)13.9 (d LJ)108.9 (.)-275 (Neur)33.9 (oendocrine perturba)29.1 (tions in)]TJ
1.7672 -1.2 Td
[(fibr)33.9 (om)27.1 (y)20 (algia and chr)33.9 (onic fa)29 (tigue syndr)33.9 (ome)56.9 (.)-275 (Rheum Dis Clin)]TJ
T*
(North Am 2000;26:989-1002.)Tj
-0.03 Tc -1.7672 -1.2 Td
[(3)-30 (1)-30 (.)-526.1 (Lautenschla)22 (ger J)86.9 (,)-245 (Bruckle W)145 (,)-245 (Schnorr)12.9 (enber)27.1 (ger CC)29.1 (,)-245 (Muller W)167 (.)]TJ
1.7672 -1.2 Td
[(Measuring pr)12.9 (essur)13 (e pain of)-337.8 (tendons and m)21 (uscles in health)55.9 (y pr)33.9 (obands)]TJ
T*
[(and pa)29 (tients with gener)7.1 (aliz)-13.7 (ed tendom)27.1 (y)40 (opa)29.1 (th)55.9 (y \(fibr)33.9 (om)27.1 (y)20 (algia)]TJ
-0.007 Tc 0.02699 Tw T*
[(syndr)41.9 (ome\))-262 ([Ger)-22.8 (man].)-272 (Z Rheuma)27 (tol 1988;47:397-404.)]TJ
0 Tc 0.02499 Tw -1.7672 -1.2 Td
[(32.)-496.1 (Quimb)20 (y L)21 (G)43 (,)-275 (Block SR,)-275 (Gr)7.1 (a)29.1 (twick GM.)-275 (Fibr)33.9 (om)27.1 (y)20 (algia:)-275 (gener)7.1 (aliz)-13.7 (ed)]TJ
1.7672 -1.2 Td
[(pain intoler)7.1 (ance and manif)40 (old symptom r)12.9 (eporting.)-275 (J Rheuma)29.1 (tol)]TJ
0 Tw T*
(1988;15:1264-70.)Tj
0.02499 Tw -1.7672 -1.2 Td
[(33.)-496.1 (T)74 (unks E,)-275 (Cr)33.9 (ook J)86.9 (,)-275 (Nor)-20.7 (man G)43 (,)-275 (K)13.9 (alaher S)50.1 (.)-275 (T)74 (ender points in)]TJ
1.7672 -1.2 Td
[(fibr)33.9 (om)27.1 (y)20 (algia.)-275 (P)12.9 (ain 1988;34:11-9.)]TJ
-1.7672 -1.2 Td
[(34.)-496.1 (Mikk)33 (elsson M,)-275 (La)29.1 (tikka P)116 (,)-275 (K)13.9 (autiainen H,)-275 (Isomeri R,)-275 (Isomaki H.)]TJ
1.7672 -1.2 Td
[(Muscle and bone pr)12.9 (essur)13 (e pain thr)12.9 (eshold and pain toler)7.1 (ance in)]TJ
T*
[(fibr)33.9 (om)27.1 (y)20 (algia pa)29 (tients and contr)33.9 (ols)64 (.)-275 (Ar)12.9 (ch Ph)55.9 (ys Med R)54 (eha)43 (bil)]TJ
0 Tw T*
(1992;73:814-8.)Tj
-0.015 Tc 0.02499 Tw -1.7672 -1.2 Td
[(3)-15 (5)-15 (.)-511.1 (K)66.9 (osek E,)-260 (Ekholm J)86.9 (,)-260 (Hansson P)148.9 (.)-260 (Incr)12.9 (eased pr)12.9 (essur)12.9 (e pain sensibility in)]TJ
1.7672 -1.2 Td
[(fibr)33.9 (om)27.1 (y)20 (algia pa)29 (tients is loca)29 (ted deep to the skin b)22 (ut not r)12.9 (estricted to)]TJ
T*
[(m)21 (uscle tissue)56.9 (.)-260 (P)12.9 (ain 1995;63:335-9.)]TJ
0 Tc -1.7672 -1.2 Td
[(36.)-496.1 (W)108.9 (olfe F)120.1 (,)-275 (Sm)27.1 (ythe HA,)-275 (Y)103 (un)35.9 (us MB)29 (,)-275 (et al.)-275 (The American College of)]TJ
1.7672 -1.2 Td
[(Rheuma)29.1 (tolo)21 (gy 1990 criteria f)40 (or the classifica)29.1 (tion of)-367.8 (fibr)33.9 (om)27.1 (y)20 (algia.)]TJ
T*
[(R)54 (eport of)-367.8 (the Multicenter Criteria Committee)56.9 (.)-275 (Arthritis Rheum)]TJ
0 Tw T*
(1990;33:160-72.)Tj
0.02499 Tw -1.7672 -1.2 Td
[(37.)-496.1 (Ashina M,)-275 (Stallknecht B)29.1 (,)-275 (Bendtsen L,)-275 (et al.)-275 (T)74 (ender points ar)12.9 (e not)]TJ
1.7672 -1.2 Td
[(sites of)-367.8 (ongoing inf)-6.8 (lamma)29.1 (tion \321 in vi)13.9 (v)27.1 (o e)13.9 (vidence in pa)29.1 (tients with)]TJ
T*
[(chr)33.9 (onic tension-type headache)56.9 (.)-275 (Cephalalgia 2003;23:109-16.)]TJ
-1.7672 -1.2 Td
[(38.)-496.1 (Kr)7.1 (a)74.9 (vis MM,)-275 (Munk PL,)-275 (McCain GA,)-275 (V)81.1 (ellet AD)50 (,)-275 (Le)13.9 (vin MF)132.1 (.)-275 (MR)]TJ
1.7672 -1.2 Td
[(ima)22 (ging of)-367.8 (m)21 (uscle and tender points in fibr)33.9 (om)27.1 (y)20 (algia.)-275 (J Ma)22 (gn)]TJ
T*
[(R)54 (eson Ima)22 (ging 1993;3:669-70.)]TJ
-1.7672 -1.2 Td
[(39.)-496.1 (J)40 (eschonneck M,)-275 (Gr)34 (ohmann G)43 (,)-275 (Hein G)43 (,)-275 (Spr)33.9 (ott H.)-275 (Abnor)-20.8 (mal)]TJ
1.7672 -1.2 Td
[(micr)33.9 (ocir)12.9 (cula)29.1 (tion and temper)7.1 (a)29.1 (tur)12.9 (e in skin a)43 (bo)33 (v)13.9 (e tender points in)]TJ
T*
[(pa)29.1 (tients with fibr)33.9 (om)27.1 (y)20 (algia.)-275 (Rheuma)29.1 (tolo)21 (gy Oxf)40 (or)13.9 (d 2000;39:917-21.)]TJ
-1.7672 -1.2 Td
[(40.)-496.1 (Simms R)116 (W)167 (.)-275 (Is ther)12.9 (e m)21 (uscle pa)29.1 (tholo)21 (gy in fibr)33.9 (om)27.1 (y)20 (algia syndr)33.9 (ome?)]TJ
1.7672 -1.2 Td
(Rheum Dis Clin North Am 1996;22:245-66.)Tj
-1.7672 -1.2 Td
[(41.)-496.1 (Staud R,)-275 (V)27.1 (ier)12.9 (ck CJ)86.9 (,)-275 (Cannon RL,)-275 (Mauder)7.1 (li AP)116 (,)-275 (Price DD)56.9 (.)]TJ
1.7672 -1.2 Td
[(Abnor)-20.7 (mal sensitiza)29.1 (tion and tempor)7.1 (al summa)29 (tion of)-367.8 (second pain)]TJ
T*
[(\(wind-up\) in pa)29.1 (tients with fibr)33.9 (om)27.1 (y)20 (algia syndr)33.9 (ome)56.9 (.)-275 (P)12.9 (ain)]TJ
0 Tw T*
(2001;91:165-75.)Tj
0.02499 Tw -1.7672 -1.2 Td
[(42.)-496.1 (V)81.1 (erne GN)56.9 (,)-275 (Hines NC)29.1 (,)-275 (R)87.9 (obinson ME,)-275 (et al.)-275 (Centr)7.1 (al r)12.9 (epr)12.9 (esenta)29.1 (tion)]TJ
1.7672 -1.2 Td
[(of)-367.8 (viscer)7.1 (al and cutaneous h)55.9 (ypersensiti)13.9 (vity in the irrita)43 (b)13.9 (le bo)27.1 (w)14.9 (el)]TJ
T*
[(syndr)33.9 (ome)56.9 (.)-275 (P)12.9 (ain 2003;103:99-110.)]TJ
-1.7672 -1.2 Td
[(43.)-496.1 (Staud R,)-275 (R)87.9 (obinson ME,)-275 (V)27.1 (ier)12.9 (ck CJ Jr)94 (,)-275 (Cannon RL,)-275 (Mauder)7.1 (li AP)116 (,)]TJ
1.7672 -1.2 Td
[(Price DD)56.9 (.)-275 (R)42 (a)29.1 (tings of)-367.8 (e)13.9 (xperimental pain and pain-r)12.9 (ela)29.1 (ted nega)29.1 (ti)13.9 (v)13.9 (e)]TJ
T*
[(af)29.1 (fect pr)13 (edict clinical pain in pa)29.1 (tients with fibr)33.9 (om)27.1 (y)20 (algia syndr)33.9 (ome)56.9 (.)]TJ
T*
[(P)12.9 (ain 2003;105:215-22.)]TJ
ET
0 0 0 0 k
315 742.5 243.036 -652.464 re
f*
BT
0 0 0 1 k
/T1_0 1 Tf
-0.00999 Tc 8 0 0 8 316 735.7637 Tm
[(4)-10 (4)-10 (.)-506.1 (V)27.1 (ier)12.9 (ck CJ Jr)94 (,)-265 (Staud R,)-265.1 (Price DD)50 (,)-265 (Cannon RL,)-265.1 (Mauder)7.1 (li AP)116 (,)]TJ
1.7672 -1.2 Td
[(Martin AD)56.9 (.)-265 (The ef)29 (fect of)-357.8 (maximal e)13.9 (x)12.9 (er)12.9 (cise on tempor)7 (al summa)29 (tion)]TJ
0 Tc T*
[(of)-367.8 (second pain \(wind-up\) in pa)29.1 (tients with fibr)33.9 (om)27.1 (y)20 (algia syndr)33.9 (ome)56.9 (.)]TJ
T*
[(J P)12.9 (ain 2001;2:334-44.)]TJ
-1.7672 -1.2 Td
[(45.)-496.1 (Mense S)43 (,)-275 (Simons DG)43 (,)-275 (R)74 (ussell IJ)108.9 (.)-275 (Muscle pain:)-275 (understanding its)]TJ
1.7672 -1.2 Td
[(na)29.1 (tur)13 (e)50.1 (,)-275 (dia)22 (gnosis)50.1 (,)-275 (and tr)12.9 (ea)29.1 (tment.)-275 (Philadelphia:)-275 (Lippincott)]TJ
T*
[(W)23 (illiams and W)23 (ilkins;)-275 (2000.)]TJ
-0.00999 Tc -1.7672 -1.2 Td
[(4)-10 (6)-10 (.)-506.1 (K)66.9 (osek E,)-265 (Ekholm J)108.8 (.)-265 (Modula)29 (tion of)-357.8 (pr)12.9 (essur)12.9 (e pain thr)12.9 (esholds during)]TJ
0 Tc 1.7672 -1.2 Td
[(and f)40 (ollo)27.1 (wing isometric contr)7.1 (action.)-275 (P)12.9 (ain 1995;61:481-6.)]TJ
-1.7672 -1.2 Td
[(47.)-496.1 (K)66.9 (osek E,)-275 (Ekholm J)86.9 (,)-275 (Hansson P)148.9 (.)-275 (Modula)29.1 (tion of)-367.8 (pr)12.9 (essur)13 (e pain)]TJ
1.7672 -1.2 Td
[(thr)13 (esholds during and f)40 (ollo)27.1 (wing isometric contr)7.1 (action in pa)29.1 (tients)]TJ
T*
[(with fibr)33.9 (om)27.1 (y)20 (algia and in health)55.9 (y contr)33.9 (ols)64 (.)-275 (P)12.9 (ain 1996;64:415-23.)]TJ
0.03999 Tc -1.7672 -1.2 Td
[(4)40 (8)40 (.)-456.1 (Y)103 (un)35.9 (us MB)29 (,)-315 (K)13.9 (al)21 (y)20 (an-R)42 (aman UP)148.9 (.)-315 (Muscle biopsy findings in)]TJ
1.7672 -1.2 Td
[(primary fibr)33.9 (om)27.1 (y)20 (algia and other f)40 (or)-20.7 (ms of)-407.8 (nonarticular)]TJ
T*
[(rheuma)29 (tism.)-315 (Rheum Dis Clin North Am 1989;15:115-34.)]TJ
0 Tc -1.7672 -1.2 Td
[(49.)-496.1 (Bengtsson A.)-275 (The m)21 (uscle in fibr)33.9 (om)27.1 (y)20 (algia.)-275 (Rheuma)29.1 (tolo)21 (gy Oxf)40 (or)13.9 (d)]TJ
0 Tw 1.7672 -1.2 Td
(2002;41:721-4.)Tj
0.02499 Tw -1.7672 -1.2 Td
[(50.)-496.1 (K)13.9 (al)21 (y)20 (an-R)42 (aman UP)116 (,)-275 (K)13.9 (al)21 (y)20 (an-R)42 (aman K,)-275 (Y)103 (un)35.9 (us MB)29.1 (,)-275 (Masi A)61 (T)111.1 (.)]TJ
1.7672 -1.2 Td
[(Muscle pa)29.1 (tholo)21 (gy in primary fibr)33.9 (om)27.1 (y)20 (algia syndr)33.9 (ome:)-275 (a light)]TJ
T*
[(micr)33.9 (oscopic,)-275 (histochemical and ultr)7.1 (astructur)7.1 (al stud)29.1 (y)115 (.)-275 (J Rheuma)29.1 (tol)]TJ
0 Tw T*
(1984;11:808-13.)Tj
0.00459 Tc 0.02541 Tw -1.7672 -1.2 Td
[(51.)-491.5 (Y)102.6 (u)-0.4 (n)35.5 (us MB)28.7 (,)-280.4 (K)13.5 (al)20.6 (y)19.6 (an-R)41.6 (aman UP)115.6 (,)-280.4 (Masi A)60.6 (T)103.6 (,)-280.4 (Alda)21.6 (g JC)28.7 (.)-280.4 (Electr)33.6 (on)]TJ
0.005 Tc 0.02499 Tw 1.7672 -1.2 Td
[(micr)34 (oscopic studies of)-372.7 (m)21 (uscle biopsy in primary fibr)34 (om)27.1 (y)20 (algia)]TJ
T*
[(syndr)34 (ome:)-280 (a contr)33.9 (olled and b)13.9 (linded stud)29.1 (y)115 (.)-280 (J Rheuma)29.1 (tol)]TJ
0 Tw T*
(1989;16:97-101.)Tj
-0.035 Tc 0.02499 Tw -1.7672 -1.2 Td
[(5)-35 (2)-35 (.)-531.1 (De Stefano R,)-240 (Selvi E,)-240 (V)27.1 (illano)32.9 (v)20 (a M,)-240 (et al.)-240 (Ima)22 (ge anal)21 (ysis quantifica)29 (tion)]TJ
1.7672 -1.2 Td
[(of)-332.8 (substance P imm)20.9 (unor)12.9 (eacti)13.9 (vity in the tr)7 (a)21 (pezius m)21 (uscle of)-332.8 (pa)29.1 (tients)]TJ
T*
[(with fibr)33.9 (om)27.1 (y)20 (algia and m)27.1 (y)40 (ofascial pain syndr)33.9 (ome)56.9 (.)-240 (J Rheuma)29 (tol)]TJ
0 Tw T*
(2000;27:2906-10.)Tj
0 Tc 0.02499 Tw -1.7672 -1.2 Td
[(53.)-496.1 (Cairns BE,)-275 (Hu JW)145 (,)-275 (Ar)12.9 (endt-Nielsen L,)-275 (Sessle BJ)86.9 (,)-275 (Sv)13.9 (ensson P)148.9 (.)-275 (Se)13.9 (x-)]TJ
1.7672 -1.2 Td
[(r)12.9 (ela)29.1 (ted dif)29.1 (fer)13 (ences in human pain and r)7.1 (a)29 (t af)29.1 (fer)12.9 (ent dischar)27.1 (ge)]TJ
T*
[(e)13.9 (v)27.1 (ok)33 (ed b)20 (y injection of)-367.8 (glutama)29.1 (te into the masseter m)21 (uscle)56.9 (.)-275 (J)]TJ
T*
[(Neur)33.9 (oph)55.9 (ysiol 2001;86:782-91.)]TJ
-1.7672 -1.2 Td
[(54.)-496.1 (Mense S)50.1 (.)-275 (Nociception fr)33.9 (om sk)33 (eletal m)21 (uscle in r)12.9 (ela)29.1 (tion to clinical)]TJ
1.7672 -1.2 Td
[(m)21 (uscle pain.)-275 (P)12.9 (ain 1993;54:241-89.)]TJ
-1.7672 -1.2 Td
[(55.)-496.1 (Gr)7.1 (a)74.9 (v)13.9 (en-Nielsen T)104 (,)-275 (Mense S)50.1 (.)-275 (The peripher)7.1 (al a)21 (ppar)7.1 (a)29 (tus of)-367.8 (m)21 (uscle)]TJ
1.7672 -1.2 Td
[(pain:)-275 (Evidence fr)33.9 (om animal and human studies)64 (.)-275 (Clin J P)12.9 (ain)]TJ
0 Tw T*
(2001;17:2-10.)Tj
0.02499 Tw -1.7672 -1.2 Td
[(56.)-496.1 (Sv)13.9 (ensson P)116 (,)-275 (Cairns BE,)-275 (W)82 (ang KL,)-275 (et al.)-275 (Glutama)29.1 (te-e)13.9 (v)27.1 (ok)33 (ed pain)]TJ
1.7672 -1.2 Td
[(and mechanical allod)29.1 (ynia in the human masseter m)21 (uscle)56.9 (.)-275 (P)12.9 (ain)]TJ
0 Tw T*
(2003;101:221-7.)Tj
0.015 Tc 0.02499 Tw -1.7672 -1.2 Td
[(5)15 (7)15 (.)-481.1 (Mar)13 (chettini P)116 (,)-290 (Simone D)59.1 (A,)-290 (Ca)21 (puti G)43 (,)-290 (Ochoa JL.)-290 (P)12.9 (ain fr)33.9 (om)]TJ
1.7672 -1.2 Td
[(e)13.9 (x)20 (cita)29.1 (tion of)-382.8 (identified m)21 (uscle nociceptors in humans)64 (.)-290 (Br)7.1 (ain R)54 (es)]TJ
0 Tw T*
(1996;740:109-16.)Tj
0 Tc 0.02499 Tw -1.7672 -1.2 Td
[(58.)-496.1 (Simone D)59.1 (A,)-275 (Mar)13 (chettini P)116 (,)-275 (Ca)21 (puti G)43 (,)-275 (Ochoa JL.)-275 (Identifica)29.1 (tion of)]TJ
1.7672 -1.2 Td
[(m)21 (uscle af)29.1 (fer)13 (ents subserving sensa)29.1 (tion of)-367.8 (deep pain in humans)64 (.)-275 (J)]TJ
T*
[(Neur)33.9 (oph)55.9 (ysiol 1994;72:883-9.)]TJ
-1.7672 -1.2 Td
[(59.)-496.1 (K)60.1 (umaza)62 (w)19.1 (a T)104 (,)-275 (Mizum)21 (ur)7.1 (a K.)-275 (The pol)21 (ymodal C-fiber r)12.9 (eceptor in)]TJ
1.7672 -1.2 Td
[(the m)21 (uscle of)-367.8 (the do)21 (g.)-275 (Br)7.1 (ain R)54 (es 1976;101:589-93.)]TJ
-1.7672 -1.2 Td
[(60.)-496.1 (Mense S)50.1 (.)-275 (Muscular nociceptors)64 (.)-275 (J Ph)55.9 (ysiol P)12.9 (aris 1977;73:233-40.)]TJ
T*
[(61.)-496.1 (Gr)7.1 (a)74.9 (v)13.9 (en-Nielsen T)104 (,)-275 (Mense S)50.1 (.)-275 (The peripher)7.1 (al a)21 (ppar)7.1 (a)29 (tus of)-367.8 (m)21 (uscle)]TJ
1.7672 -1.2 Td
[(pain:)-275 (e)13.9 (vidence fr)33.9 (om animal and human studies)64 (.)-275 (Clin J P)12.9 (ain)]TJ
0 Tw T*
(2001;17:2-10.)Tj
0.02499 Tw -1.7672 -1.2 Td
[(62.)-496.1 (Sor)12.9 (ensen J)86.9 (,)-275 (Gr)7.1 (a)75 (v)13.9 (en-Nielsen T)104 (,)-275 (Henriksson K)80.1 (G)43 (,)-275 (Bengtsson M,)]TJ
1.7672 -1.2 Td
[(Ar)12.9 (endt-Nielsen L.)-275 (Hyper)12.9 (e)13.9 (x)20 (cita)43 (bility in fibr)33.9 (om)27.1 (y)20 (algia.)-275 (J Rheuma)29.1 (tol)]TJ
0 Tw T*
(1998;25:152-5.)Tj
ET
0 0 0 0 k
53.964 64.884 513.774 -14.987 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
8 0 0 8 54.964 58.1473 Tm
(28)Tj
0.02499 Tw 36.8512 0 Td
[(The J)50.1 (ournal of)-345.8 (Rheumatolog)13.9 (y 2005,)-275 (V)72 (olume 32 Supplement 75)]TJ
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
106.328 69 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
63 0 obj
<>stream
8;Z\6$$+cS%)i01M!lUKZj0.KOuoLQRLsqcM*W,>`A3jBr?@.aO8+!S5(A('T9#E:
mX->ZRqS]mfXX,9b*IjIG`.fE`JPm8`$3n1/4$%foIheZp"0emMiDp,:XP!"=+?1e
#aLE0O?+F]A]3Ld03%H_8BT.hP.<4=?mQR&d.g%r2T$ajB/[Rp[[]&?*Md\?87Y!g
4c;oM),D@=20UU3l6BSlVsQC")$`aa@8P,Kj9Vsk^E`QI*Mi.)1\NA@
EAAMUa0%Z0#2-f^P:uXS1A*mX#<>oo)9DPdf95!%:,-:h-TLPo(ga.rsUjg]McY+at5&1%]I4":q[eI$cEi&8$+Ub6h?#7EB;ch3;Y!4X2d9*pe
oDqJ&]PSg.jLd:K7,R.?n"=6hML%SQPNhMhX0c!#ZHt28b.U]m,Ha[`?$S@ZX8"!?
1MM54F!Pr;FX-@'(RlbN%>AEYd.+2K?Aes?UC?4fP*IjdeAR6kX'g]f(]QkhZ&=R:
P2Adr\@QFWK;,=Qp%5fL,oQ1LBgq]
1DY^TQf4T3qV/u72'k:/"17B]p0UI%f:^S@loi-L82P&HBW5fZ.CF4>C,lmr@Rq7[
)n"ebnh3tZ.Pl(MN)G.^
Fj^4pG#`s(3#_'kfuO:VgHq6l!1fHC`'#*[&1OFCl7*,6U=ECJ461Ol;H?^Y':qiV
[onhD&ngutK1;,A@i<]A?;Ya"X[Skn]%2tUX/h:Ep=NmTX2XtE]:sXI\mTK^o4E76
Z,XK^!!RGEqZ~>
endstream
endobj
67 0 obj
[/Indexed/DeviceRGB 255 66 0 R]
endobj
66 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
90 0 obj
<>
endobj
112 0 obj
<>
endobj
127 0 obj
<>
endobj
181 0 obj
<>
endobj
113 0 obj
<>
endobj
118 0 obj
<>stream
HlTiTSpo`( !W.آbE
! ""a"8kyN8UZeV9<þwAtY8{oOp q+pAp@ࢱE>Sl9 87ĉ*༜
Nvw=L-vB\uvȐfkqcuџ'N>ARʗ:eV>C&9Q)c|j]+OVjɩʘ䋔iPMb}{daS/=gxcHΎlּ\KҼ c
v^r8DLjlJ]K%5a/VpYwlǼIűEgGGT\Z|}]IЪص[Xqq*\ᖦJmϢ֓IC!]B_+d{>贘&sxsm\pIi"}PXو٣&je
2-0Vh2#/prz9{qVѸD[xp]G_:"Q;A!yxCvcTxὛխe";:Ajm9:>+.I[c_UUo}JԐ]5_!DOrv?ѽv:ɮouJ_K'tӟOdTP5l-R/ZGlӠG bF`먕";=vi
y@lbʧWPR~WCf[vzq>nCVkoqfnoP|UHA1Z@$
G#Ƃ!Fe6U"t맧a`Oay~5;{=ZOєPt147EI'~¿^+-BQ#5b{viF}Ј*R`!hzI{
+nX!Q>>ffٶ,k¨-+~]olUW7dV?j1yLTٚzG3]WChA1EP-|Lng0m֚"
а1h.t$v!˭c&ќ aAlTܪ
J:`)i(7& = Ѫp*6#:iݺ(zU>V'5<{--x
nJSho^=ғp}]BFnwJگZ+TXYK $+JoZRebse7AA8촘RP9!^cҷ-Pݬp nzrAs+LكY!qc6ֵ{+v3e
>YuyeV~qkI3xhJ\|~ڴ|yF>/X~8uA
KIխ&scvꎹjٗa>h*5@W
Thӹ)l)Q&@DoAe61=l탄`,DBp-5r1oVhS/Uęh]Ye6-fZ>UZx֣ZEW
af&@Dl,^h)DAZ-Vuݾ<7q{;wBaTrJ<!S.&x%a1Uʵ|*tWEl:j2SPmzEp:iHњ*
MDEIp"$`0K4R=-8.U*}b{IY6,gaZB^ER.!Av=gٍ`'"G u'16%ڽ&1wv6ɭv*EJgb*Kޱh@t>=[죮B[h?º)یI9V%
q5^O3-?+}'}AU0
6\~W_Bj[~PpqR!56!f`Јb?Z%&wo{ 0U
."LiWTn]50|ƃJgUeCj5\MjI5wSjK;T+AI+ߖ+-gt^M Bc`
^Ȩ\42[z\gE-qr8ҕ$]dn4eJpdxKiFBˎyQ!{-kbJx|ƥ73h\x1=W9Ɨą=_[@^C+,A Y^W/2Su`ɨǴB,&I/dL 2 ¡);9[iHAu-Ph-۳zjoDJ]Kb/GFG|Oҙ2Ekxƞq/ ~(f!J3345 Yv9Na.ڂF`wN1)UKϨ;p-MIYvzk&